← Browse by Condition
Medical Condition

adverse event following immunisation

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for adverse event following immunisation sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4
1
Top Sponsors
Duke University 1 trial
NCT07158814 Phase 4
Recruiting

Safety of RSV Preventive Monoclonal Antibody

Enrollment
524 pts
Location
United States
Sponsor
Duke University
View Trial →